Satellos Bioscience

MSLENasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$208.937 M

$10.03 -0.40%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

15,458,903

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#264Greenwich LifeSciencesGLSI$210.8M
#265Arcturus TherapeuticsARCT$210.6M
#266Satellos BioscienceMSLE$208.9M
#267NovaBridge BiosciencesNBP$201.9M
#268Minerva NeurosciencesNERV$198.9M

Where these numbers come from

Share counts and financials for Satellos Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.